CNSF Supporters - Canadian Neurological Sciences Federation

Canadian Neurological Sciences Federation

Neuro | Newsa n n u a l e d i t i o n

2 0 1 3

unaccredited learning activitiesuse learning to create aSection 2 PLP

Limited seating for these events.

Please note delegatesattending a Lunch ‘n Learnmust pre-register as meals are ordered based on pre-attendance numbers.

Canadian Neurological Sciences Federation • 48th Annual Congress • Montreal, Quebec • June 12-14, 2013 • Pre-Congress June 111

Table of Contents

table of contents

Board of Directors ..........................................................................................................................................2About us.........................................................................................................................................................3Benefits of CNSF Membership ......................................................................................................................4Our Supporters ..............................................................................................................................................5The Canadian Journal of Neurological Sciences ...........................................................................................6Strategic Planning..........................................................................................................................................8Advocacy .....................................................................................................................................................10Clinical Practice Guidelines .........................................................................................................................10International Development ...........................................................................................................................11Industry Support ...........................................................................................................................................11Virtual Exhibit Hall ........................................................................................................................................12Continuing Professional Development.........................................................................................................132013 Congress Planning Committee ...........................................................................................................13CNSF Supporters.........................................................................................................................................14Canadian Association of Neuroscience Nurses ...........................................................................................20Associates and Affiliates ..............................................................................................................................21Canada Helps / CSCN National Fellowship.................................................................................................22Medlearn ......................................................................................................................................................23Future Congresses ......................................................................................................................................23Major Supporters .........................................................................................................................................24

2

R. Loch MacdonaldCNSF SPC ChairCNSS Member

John StewartCNSF/NSFC Past President

CNS & CSCN Member

George EllekerCPGC Co-Chair

CNS & CSCN Member

J. Max FindlayCNSF/NSFC President

CNSS Member

Chris WallaceCNSF/NSFC Vice-President

CNSS Member

Sharon WhitingCNSF/NSFC BoardCACN President

Narayan PrasadCNSF/NSFC BoardCACN Vice-President

Jeanne TeitelbaumCNSF/NSFC Vice-President

CNS Member

Brian ToyotaCNSF/NSFC BoardCNSS President

Ian FleetwoodCNSF/NSFC BoardCNSS Vice-President

Sarah KirbyCNSF/NSFC BoardCNS President

Garth BrayCNSF/NSFC Vice-President

CNS Member

Seyed MirsattariCNSF/NSFC BoardCSCN President

Kristine ChapmanCNSF/NSFC BoardCSCN Vice-President

Serena OrrCNSF/NSFC Board

Residents’ Rep. CACN

Roberto DiazCNSF/NSFC Board

Residents’ Rep. CNSS

Nailyn RasoolCNSF/NSFC BoardResidents’ Rep. CNS

Jason BartonCNSF/NSFC BoardCNS Vice-President

Dan MorinCNSF/NSFC Board

CEO

Morris FreedmanIDC Chair

CNS Member

G. Bryan YoungJournal Editor-in-ChiefCNS & CSCN Member

Chris EkongCNSF/NSFC BoardMember-At-Large

Michael HillCNSF/NSFC BoardMember-At-Large

Ron ProkrupaCNSF PDC ChairCNSS Member

Shobhan VachhrajaniCPGC Co-ChairCNSS Member

Richard RiopelleAdvocacy ChairCNS Member

Mandar JogMedlearn ChairCNS Member

2012 – 2013 Board of Directors and Committee ChairsThe Canadian Neurological Sciences Federation (CNSF) and

The Neurological Sciences Foundation of Canada (NSFC)


About us...

Neuro | News is a bi-monthly publication of the CNSF which is used to communicate relevant CNSF andSociety activities; including highlights of the Congress, member profiles, the Journal, Committee activities,Continuing Professional Development activities, Advocacy, and Membership services and benefits.

Neuro | News is just one of the many ‘mediums’ we use to communicate with members and otherorganizations associated with the CNSF; we also use the Journal, email communications and our web-siteto keep members informed of relevant activities.

Neuro | News is scheduled, designed, produced and distributed by the Secretariat, but we encouragesuggestions and submissions from all members and Societies, i.e. Society information, studies, surveys,information on Committee activities, just to name a few.

This “annual edition” of the Neuro | News is intended to provide you with a comprehensive overview of theCNSF. It also is intended to more clearly and succinctly detail the many CNSF activities and how thevolunteers comprising the CNSF Board and the CNSF Committees are working hard on your behalf toprovide you with the various benefits of joining one, or more, of the four Societies which comprise theFederation.

We hope you find this ‘annual edition’ of the Neuro | News both informative and of value.

Thank you.

Dan MorinChief Executive OfficerCanadian Neurological Sciences Federation

Our Member SocietiesThe four member societies of the CNSF are the actual ‘owners’ of the Federation. Each Society isrepresented on the CNSF Board by their President and Vice President. Individuals from the membership atlarge are elected to serve on the CNSF Executive Committee (CNSF President and 3 Vice Presidents). TheBoard also has two At-large members appointed and one official residents’ representative (and 2 non-votingresidents’ representatives).

Member Societies also nominate individuals to the major CNSF Committees, i.e. Professional Development,Scientific Program, Advocacy, Clinical Practice Guidelines, Medlearn and International Development.

In 2012, the Societies had the following number of members: CNS= 537, CNSS=308, CACN=121, and CSCN=248.


Benefits of CNSF Membership

CNSF members belong to one, or more, of our four constituent Societies.Canadian Neurological Society (CNS) Canadian Association of Child Neurology (CACN) Canadian Neurosurgical Society (CNSS) Canadian Society of Clinical Neurophysiologists (CSCN)

Canadian Journal of Neurological SciencesThe official publication of our four member societies. The Journal is a widely circulated, internationally recognized, peerreviewed medical journal.

Members receive a full subscription to the Canadian Journal of Neurological Sciences (CJNS) in hard copy and onlinethrough the CNSF Member Centre.

Members receive a $100.00 discount when paying for color graphics (if desired) to accompany their papers acceptedfor publication in the print Journal.

Members published articles, that include color graphics, are given priority for the Journal front covers.

Members are given priority as Journal “book reviewers” and they receive a complimentary book copy.

CNSF Members and Journal subscribers have exclusive access to the 2 most current years of this publication.

Annual Society Prizes Members have the opportunity to win valuable society prizes. There are 6 first place prizes available, each valued atapproximately $2500. Winners have the privilege of presenting their work at a Platform presentation at the Congress.There may also be opportunities for $500 second prizes. All details and submission information is available in the annual“Call for Abstracts book” on our website.

Annual Congress Our Federation, assisted by the Professional Development and the Scientific Program Committees, hosts an AnnualCanadian Congress geared towards the continued professional development learning needs of Neurologists,Neurosurgeons, Pediatric Neurologists, Neurophysiologists and Neuroscientists.

Members attend the CNSF Annual Congress at a generously discounted registration fee.

Our Congress is an accredited learning activity. Earn CME credits for your Continuing Maintenance of Certification.Gather with your colleagues and friends from across the country. Learn, Mentor, Share, Teach, Collaborate, Advocate

ResidentsFirst-year residents can apply for complimentary first-year membership. Subsequent years of membership duringresidency are also partially subsidized by their Society.

The CNS, CNSS and CACN, all have a resident representative on the CNSF Professional Development Committee andthe CNSF Scientific Program Committee. These committees determine the scientific program for each year’s annualmeeting. The resident representatives attend the CNSF Board of Directors meetings, as well as society and councilmeetings. Resident members are welcome to contact their society resident representative with any issues, concerns orideas that they would like to see discussed at their Society Council meeting or the CNSF Board meetings.

Scotia Professional® PlanThe CNSF and Scotiabank alliance provides CNSF members with an enhanced Scotia Professional® Plan, a flexibleprogram designed to meet your financial needs at each stage in your career. Additional information may be found withinthe CNSF Members’ Centre.

Our SupportersOur SupportersPlatinum

Gold

Silver

Supporters

Neurological Sciences Foundation of Canada

Actelion

Centogene

Pfizer

Parkinson’s Societyof Canada

Bronze

Fédérationdes sciencesneurologiquesdu Canada

canadianneurologicalsciencesFederation


The Journal, Yesterday, Today and Tomorrow

History of the JournalThe first Canadian Journal of Neurological Sciences (CJNS) was published in 1974 in Winnipeg. In 1981, the Journal becamethe official publication of the member societies of the CNSF.

The Journal publishes original work in both the clinical and basic neurosciences. The circulation is currently 1,500 and consistsof society members, non-member subscribers and institutions in Canada, the United States and abroad.

Past Journal Editors (l-r) Dr. Robert G. Lee,

Dr. Douglas W. Zochodne, Dr. Robert T. Ross, Dr. James A. Sharpe

The Journal, TodayToday, the Journal continues to encourage thepublication of papers from all branches of theneurosciences. Journal policy is based on the firm belief thatspecialists working on the nervous system sharemany common interests and have importantideas to communicate to each other.

Dr. G. Bryan Young of London, Ontario has beenEditor-in-Chief of the Journal since 2007. He willbe stepping down as of July 1, 2013. We wish tothank Dr. Young for his dedication, vision andcontribution which has greatly enhanced theJournal.

The Journal, The FutureAs of July 1, 2013, Dr. Robert Chen of Toronto, Ontario, will be assumingthe position of Editor-in-Chief of the Canadian Journal of NeurologicalSciences. Dr. Chen received MA and medical degrees (MBBChir) from theUniversity of Cambridge and M.Sc. from the University of Toronto. Heundertook internship at Guy’s Hospital (University of London), internalmedicine residency at Queen’sUniversity, Neurology residency at theUniversity of Western Ontario, andfellowship at the National Institute ofNeurological Disorders and Stroke atthe National Institutes of Health. He iscurrently Professor of Medicine(Neurology) at the University of Toronto,the Catherine Manson Chair inMovement Disorders, Senior Scientistat the Toronto Western ResearchInstitute and the Director of the EliotPhillipson Clinician Scientist TrainingProgram at the University of Toronto.His research interests are human motor physiology, brain plasticity andpathophysiology of movement disorders such as dystonia andParkinson’s disease. He has authored over 200 peer-reviewed researchpapers and two books. He is a member of the Editorial Boards of CJNS,Neurology, Clinical Neurophysiology, Muscle & Nerve, and a reviewingeditor of PLOS ONE, Frontiers in Neuroscience and Neural Plasticity.Welcome Dr. Chen!


Canadian Journal of Neurological Sciences

BackgroundThe Canadian Journal of Neurological Sciences is the official publication of the four member societies of the Canadian Neurological Sciences Federation

Canadian Neurological Society (CNS), Canadian Association of Child Neurology (CACN),Canadian Neurosurgical Society (CNSS), Canadian Society of Clinical Neurophysiologists (CSCN)

The Journal is a widely circulated internationally recognized medical journal that publishes peer-reviewed articles.The Journal is published in January, March, May, July, September, and November. (May and November are on-line only issues)

Full subscription is a Benefit of CNSF Membership.

Associate Editors * Robert Hammond (london, on)* J. Max Findlay (edmonton, ab)* Mary Connolly (vancouver, bc)* Mark Sadler (halifax, ns)* Mike Poulter (london, on)* Serge Gauthier (verdun, qc)* David Pelz (london, on)

Editorial Board * Jorge Burneo (london, on)* Richard Desbiens (quebec city, qc)* David Fortin (sherbrooke, qc)* Mark Hamilton (calgary, ab)* Hans-Peter Hartung (dusseldorf, germany)* Michael Hill (calgary, ab)

* Alan C. Jackson (winnipeg, mb)* Daniel Keene (ottawa, on)* James Perry (toronto, on)* Oksana Suchowersky (edmonton, ab)* Brian Toyota (vancouver, bc)* Brian Weinshenker (rochester, mn, usa)* Samuel Wiebe (calgary, ab)* Elaine Wirrell (rochester, mn, usa)* Mary Jenkins (london, on)* Andrew Kirk (saskatoon, sk)

Editorial Review Board * Donald Brunet (kingston, on)* Jodie Burton (calgary, ab)* Lionel Carmant (montreal, qc)* Colin Chalk (montreal, qc)

* K. Ming Chan (edmonton, ab)* Joseph Dooley (halifax, ns)* Paolo Federico (calgary, ab)* Daryl Fourney (saskatoon, sk)* Hannah Glass (san francisco, ca, usa)* Alan Goodridge (st. john’s, nl)* Ian Grant (halifax, ns)* Alan Guberman (ottawa, on)* John Hurlbert (calgary, ab)* Manouchehr Javidan (vancouver, bc)* Patrick McDonald (winnipeg, mb)* Martin McKeown (vancouver, bc)* Joseph Megyesi (london, on)* Vivek Mehta (edmonton, ab)* Steven Miller (toronto, on)* Neelan Pillay (calgary, ab)

* Christopher Power (edmonton, ab)* Alex Rajput (saskatoon, sk)* Jean Raymond (montreal, qc)* Gary Redekop (vancouver, bc)* Harvey Sarnat (calgary, ab)* John Stewart (vancouver, bc)* Jeanne Teitelbaum (montreal, qc)* Eve Tsai (ottawa, on)* Shannon Venance (london, on)* Matt Wheatley (edmonton, ab)* Jerome Yager (edmonton, ab)

Journal Staff * Dan Morin (calgary, ab)* Maggie McCallion (calgary, ab)* Cindy Leschyshyn (calgary, ab)

The Canadian Journal of Neurological Sciences (CJNS, the Journal) is the “voice” of this country’s clinical neuroscientists. For over39 years, the Journal has been the publication of choice to disseminate the work of Canada’s best and brightest neuroscientists. Asthe Journal is an international publication, it is widely subscribed to around the world and frequently features science from abroad. Arecent Canadian Association of Medical Publishers survey showed that peer-reviewed journals continue to be cited as the mostvaluable form of continuing medical education. www.cjns.org

2012 REVIEWER OF THE YEAR - Jodi Burton

Dr. Burton is a neurologist who specialized in Multiple Sclerosis (MS) and related diseases, aswell as in Clinical Epidemiology. She obtained her MD, Neurology residency, MS fellowship andMSc in Clinical Epidemiology at the University of Toronto. She was a neurologist at the MS Clinicat St. Michael’s Hospital, University of Toronto from 2007-2009 and has been an Assistant ClinicalProfessor in the Departments of Clinical Neurosciences since 2009 and Community Health Sciencesat the University of Calgary from 2011. Dr. Burton’s research activities focus on the role of vitaminD in demyelinating disease and she is involved in several studies and working groups in that area.Her work also involves reproductive hormones in CNS demyelination, Neuromyelitis Optica,escalation therapy and stem cell transplantation in demyelinating disease, specifically NeuromyelitisOptica. She is also active in Evidence Based Medicine teaching at the University of Calgary.

We are pleased to present the 2012 CJNS Reviewer of the Year Award to Dr. Jodi Burton from the University of Calgary, Calgary,Alberta. Jodi has provided excellent, timely reviews of numerous articles in Multiple Sclerosis and Clinical Epidemiology for theJournal. She has also been a faithful contributor of Journal articles. We hope we can count on her for a similar stellar performancefor years to come. G. Bryan Young, Editor-in-Chief, CJNS.


Strategic PlanningA. Introduction:

The Canadian Neurological Sciences Federation’s (CNSF) strategic plan was last re-visited in 2008. In January 2012 a process wasundertaken to review and consider the CNSF’s future strategic direction, and a draft vision, mission and values were developed andissued for consultation. Numerous meetings were held by various CNSF committees charged with the development of the new ‘plan’and several iterations of the Vision, Mission and Objectives were considered. A major component of the Plan’s development occurredat the June 2012 meeting in Ottawa where through a consultative process the Vision, Mission, Values and Strategies were reviewed,discussed and amended. Feedback from members following the June meeting was also considered. Specific strategic priorities arenow identified to reflect the current and future realities of which activities, and how the CNSF should undertake to move forward toprovide the best possible and most relevant services to its membership.

B. CNSF Vision, Mission and Values:

An organization’s vision conveys what impact is desired, and for whom. It should capture the altruistic outcome that reflects aprofession’s higher purpose.

CNSF Vision: The improved wellbeing of children and adults with diseases, disorders and injuries of the nervous system and theprevention of these conditions. An organization’s mission conveys its chosen approach to achieving the vision. It describes the broad scope of work the Federationwill undertake.

CNSF Mission: To support the neuroscience professions in Canada, and particularly those members of the CNSF’s Societies, througheducation, advocacy, membership services and research promotion.

Notes about the Mission:• Education includes the annual CNSF Congress, The Canadian Journal of Neurological Sciences (The Journal), and all othercontinuing professional development (CPD) activities.

• Advocacy includes activities such as building public awareness about diseases, disorders and injuries of the nervous system, andadvocacy for improved public policy and increased medical research. Such advocacy may be direct or in collaboration with otherorganizations.

• Membership Services include services delivered to the four constituent societies of the CNSF and their individual members, theservices offered to Society members, the research to identify member needs, and other related activities.

• Research Promotion includes clinical research undertaken in partnership with other organizations.CNSF ValuesAn organization’s values convey those non-negotiable elements in how the mission is implemented in pursuit of the vision. Valuesmean that outcomes are not the only thing that matters – how outcomes are achieved is also important. Success is not onlydetermined through outcomes, but also through conduct and approach.

Excellence in EducationContinuing professional development is a cornerstone of the success of the individual practitioner, the profession and the membersocieties. Accordingly, all of the CNSF’s educational efforts must reflect excellence in their quality, relevance and delivery.

Representative and InclusiveThe CNSF is a federation of Societies representing diverse and collegial medical professionals with a common focus on diseases,disorders and injuries of the nervous system. Accordingly, the CNSF must reflect and engage these Societies and their members inhow it works and what it does.

A Strong and Effective VoiceThe wellbeing of individuals with diseases, disorders and injuries of the nervous system and, where possible, the prevention of theseconditions, comprise an important vision. The work of the member societies and their respective members is also important. TheCNSF must advocate with a strong and effective voice knowing that its mission and vision have unique and important value to society.

Responsible StewardshipThe CNSF’s financial resources are secured from the dues paid by the professionals of its constituent Societies and from commercialsponsors who support its vision and mission. The CNSF has an obligation to the professionals of its constituent Societies to managethese resources wisely, maintain good governance practices, and conform to the standards established on behalf of society by theresponsible agencies (e.g. governments, the RCP&SC, provincial and territorial regulatory bodies).


Strategic PlanningC. The CNSF Strategic Priorities:

The strategic priorities identify those initiatives for the next 12-24 months that relate to the purpose of the organization and its direction,and as a result, will require the specific attention and focus of the CNSF leadership, and the clear identification of specific prioritiesthat are based on member preferences, and the resources of the CNSF. The CNSF activities that support the neuroscienceprofessions in Canada can be categorized into one of three strategic priorities.

To ensure the achievement of its Vision and Mission, the CNSF has three strategic priorities: Continuing Professional Development;Membership Value; and Advocacy. The main objectives of these three priorities are listed in this section. In addition, responsibilityfor expanding and putting these elements into operation has been assigned to one or more of the CNSF constituent societies,committees, or staff.

1. Continuing Professional Development: The goal of this priority is to review, refine, improve and expand the overall CNSF CPDplan to meet the evolving needs of Society members while continuing to focus on the CNSF’s priorities, i.e. the Congress and theJournal. To achieve the goal of this priority, the CNSF will:

1.1 Identify and document emerging perceived and unperceived educational needs of members. Responsibility: PDC, Staff.1.2 Continually evaluate the Congress through periodic assessments of its effectiveness in meeting member needs. Responsibility:

PDC, SPC, Staff.1.3 Develop and implement a Journal Operational Plan that will increase the impact factor and ensure the Journal prospers and is

managed to thrive in a digital world. Responsibility: Journal Editor, Editorial Board, Staff.1.4 Promote the development of Clinical Practice Guidelines. Responsibility: CPGC, Staff.1.5 Continue with the redefinition of the objectives, scope and content of Medlearn. Responsibility: Medlearn Committee, Executive,

Staff

2. Membership Value: The goal is to build a strong organization that provides value to the constituent societies and their growingmemberships. To achieve the goal of this priority, the CNSF will:

2.1 Increase the Constituent Society membership. Responsibility: Society Executives, Councils, Staff.2.2 Encourage the participation of residents. Responsibility: Societies, Resident Representatives, Staff.2.3 Review and, if necessary, revise governance and operational capabilities to assure they achieve the CNSF Vision and Mission.

Responsibility: Governance Committee, Staff.2.4 Maintain ongoing and reliable measurements of current professional resources. Responsibility: Societies, Staff.2.5 Provide other added value for members to encourage increased Society membership. Responsibility: Society Councils,

Executives, Staff.2.6 Develop and grow resources to implement strategies. Responsibility: Staff, Board.2.7 Measure and evaluate the success of strategies to achieve the CNSF Vision and Mission. Responsibility: CNSF Board.2.8 Facilitate International Development opportunities for CNSF members. Responsibility: IDC, Staff.

3. Advocacy: The goal is to increase awareness of the impact and burden of diseases, disorders and injuries of the nervous systemin Canada on affected individuals, their families, and communities, and the health-care system. The targets of this priority are thepolicy-makers at all levels of government, the general public and affiliated health care providers. To achieve the priority ofstrengthening the profession through the building of relationships the CNSF will:

3.1 Work and/or partner with Affiliate and Associate Societies and other related organizations to increase awareness of neurologicalconditions. Responsibility: Advocacy Committee, Board, Societies, Staff.

3.2 Influence public policy decisions on matters related to the CNSF Vision concerning the prevention, diagnosis and managementof neurological conditions. Responsibility: Advocacy Committee, Board, Societies, Staff.

3.3 Advocate for support for basic neuroscience and applied research, including strategies for prevention of neurological conditions.Responsibility: Advocacy Committee, Board, Societies, Staff.


Advocacy

In 2008 a coalition called Neurological Health Charities Canada (NHCC) was formed by most of the SpecialtySocieties that represent specific neurological disease/disorder groups from across Canada. The NHCC’spurpose is to serve as one voice that will provide a stronger sense of community and influence for positivechange in the neurosciences. The NHCC rapidly evolved into an effective organization that obtained financialsupport from both the Federal and Ontario governments for two important projects concerning the incidenceand management of the disabilities caused by chronic neurological conditions. Because the CNSF and theNHCC have almost identical objectives with respect to advocacy, the CNSF accepted the invitation to jointhe NHCC and to channel its current advocacy efforts though that coalition; while maintaining itsindependence for other internal advocacy activities.

The Advocacy Committee is chaired by Richard Riopelle. Committee members include: Garth Bray, Michael Hill and Max Findlay.

Clinical Practice Guidelines

In June 2010 the CNSF Board of Directors created a Clinical Practice Guidelines Committee (CPGC) todevelop recommendations on how to deal with requests to endorse best-practice guidelines. In November2010, the CPGC affirmed that the endorsement of Clinical Practice Guidelines (CPG) is an appropriate rolefor the CNSF and approved a set of criteria and processes that had been drafted based on the principlesand policies developed by the Canadian Stroke Network for its “Stroke Strategy”. These criteria andprocedures were subsequently approved by the CNSF Board of Directors in November 2010.

The goals of the Clinical Practice Guidelines Committee are to: 1. Encourage the development, dissemination and implementation of clinical practice guidelines by the Affiliate

Societies and other groups that represent the sub-specialties of Neurology and Neurosurgery.2. Establish a framework and processes for the promotion and endorsement of clinical practice guidelines so

that evidence-based guidelines meet the needs of, and can be communicated effectively to, the CNSFmember Societies and their individual members.

3. Investigate the potential for adapting and adopting Clinical Practice Guidelines developed in other countries,particularly the USA and Europe, for member use in Canada.

The Clinical Practice Guidelines Committee is co-chaired by George Elleker and ShobhanVachhrajani. Committee members include: Derek Fewer, Lyle Weston, Sharon Whiting,Elizabeth Donner, Richard Riopelle and Garth Bray.


International Development

The CNSF International Development Committee (IDC) is responsible for building relationships with developingcountries in the area of neurological sciences; relationships which will be mutually beneficial to those countries andto the CNSF. The IDC is a relatively new committee and as such is still in the early stages of development and in the establishmentof specific ‘plans’ for future activities. The primary goal of IDC is to facilitate participation of CNSF members in International Development throughcollaboration with international organizations of neuroscience professionals such as the World Federation ofNeurology, the World Federation of Neurosurgery and others to provide CNSF members with information on how toindividually participate in international development activities.The IDC is Chaired by Morris Freedman with Narayan Prasad serving as Vice Chair. The remaining committeestructure is currently under review.

NOTES: All CNSF Committees are appointed by and accountable to the CNSF Board of Directors and provide reports of theiractivities at each Board meeting.

Additional information on all CNSF Committees is available by contacting Dan Morin at the CNSF Secretariat; [email protected]

Industry Support

Much has been discussed recently about industry, i.e. pharma, medical equipment companies, banksand all other sectors, which support Specialty Societies, including the CNSF. It is safe to say that theCNSF’s relationship with all its sponsors, exhibitors and supporters is an excellent one; based onhonesty, integrity and transparency.

As important is the fact that the CNSF develops all of its CPD activities, including the Congress program, independentof any ‘industry’ input. Put simply, the CNSF follows the Royal College’s rules and regulations to the fullest extent,and develops its CPD activities based on members’ feedback (perceived and unperceived needs) from Congressevaluations, Membership surveys and other methods of information gathering.

Put simply, and honestly, the CNSF could not survive without the relationship, and support, the CNSF has with allindustry sectors. We, and they, work hard to maintain the honesty, integrity and transparency mentioned earlier.

So, in spite of recent changes to the rules that govern us and how we recognize donors, industry still supports theCNSF throughout the year…at our Congress, through our Journal and in our other CPD activities. Industry is verygenerous year after year in their provision of unrestricted and unconditional grants to the CNSF.

We have listed all the companies that have supported us this year and provided you with a précis of who they areand what that support entails. Be reminded that nowhere has industry had any input into any of our CPD activities.


Virtual Exhibit Hall

Learn about the CNSF Congress Sponsors and Exhibitors at our VEH...

The purpose of the CNSF Virtual Exhibit Hall (VEH) is to showcase Sponsors and Exhibitors within an onlineenvironment to highlight not only what their company is about, but to also highlight their involvement in theCanadian Neurological Community.

In the coming years we will be encouraging our Sponsors and Exhibitors to include news items, grants,fellowships and awards which they offer to the Neurological Community to profile the work they do for you,in addition to the pharmaceuticals, medical devices and other services provided. We also hope to increasethe number of VEH booths providing emails so you can contact representatives directly, and at your leisure,as your needs and the needs of your patients require further assistance.

Please take time to view the first Medical National Specialty Society Virtual Exhibit Hall in Canada andprovide us with feedback, within the 2013 Online Overall Congress Evaluation. Tell us what you believewould make your experience in the CNSF Virtual Exhibit Hall more relevant and meaningful.

Visit our Sponsors & Exhibitors Online at http://veh.cnsfederation.org/


Continuing Professional Development

The CNSF is committed to providing relevant Continuing Professional Development (CPD) opportunities to its membersand to Neurologists and Neurosurgeons, in general. Both the Canadian Neurolgical Society and the CanadianNeurosurgical Society, member societies of the CNSF, are accredited providers of the Royal College’s Maintenance ofCertification (MOC) program.

One of the CNSF’s primary CPD activities is, of course, the Congress. Planning for the Congress is a year round activityand involves a review of past Needs Assessments and Evaluations; including Congress Specific Course Evaluations,Overall Congress Evaluations, Auditor Evaluations and the results of the CNSF Membership Needs Assessment andSatisfaction Survey.

The Professional Development (PDC) and Scientific Program (SPC) Committees work collaboratively to develop eachyear’s Congress program; ultimately approved by the CNSF Board and its Societies.

The Professional Development Committee is responsible to determine members’ educational needs, facilitate learningopportunities and advise the CNSF Board with respect to ongoing professional development of the members of the fourconstituent Societies. The PDC through the analysis and review of Needs Assessments provides suggestions for Coursetopics and content based on the summaries.

The Scientific Program Committee is responsible for creating learning activities for the Congress, based on the NeedsAssessment and Evaluation Summaries and the recommendations of the PDC. The SPC recruits Chairs and Speakersand provides as much information as necessary which reflects members’ needs and preferences which the Chairs andSpeakers use to create their Courses. The inclusion of CanMeds roles within courses/sessions is encouraged. Thecommittee oversees and coordinates the Congress’ educational courses, satellite symposia and workshops, abstractadjudication and program structure.

2013 Congress Planning CommitteeThe Canadian Neurological Sciences Federation (CNSF) is composed of 4 Societies:

Canadian Neurological Society (CNS)Canadian Association of Child Neurology (CACN)

Canadian Neurosurgical Society (CNSS)Canadian Society of Clinical Neurophysiologists (CSCN)

Members from each of the 4 Societies have representation on our Congress planning committee(s)The Professional Development Committee (PDC) and the Scientific Program Committee (SPC).

This year's Planning Committee is comprized of:

Ron Pokrupa PDC Chair (CNSS)Bev Prieur PDC Vice-Chair (CACN, CNS)Robert Loch Macdonald SPC Chair (CNSS)Draga Jichici SPC Vice-Chair (CNS)Asif Doja PDC (CACN)Chris Wallace CNSF Vice-President, PDC (CNSS)Craig Campbell SPC (CACN)Danielle Andrade SPC (CSCN)Eric Massicotte SPC (CNSS)Garth Bray CNSF Vice-President, PDC (CNS)J. Max Findlay CNSF President, SPC (CNSS)James Perry SPC (CNS)

Jeanne Teitelbaum CNSF Vice-President, SPC (CNS)Joseph Megyesi PDC (CNSS)Lawrence Korngut SPC (CNS, CSCN)Michael Hill CNSF Board, SPC (CNS)Michelle Demos SPC (CACN)Nailyn Rasool SPC, PDC (CNS)Roberto Diaz SPC, PDC (CNSS)Roger McKelvey PDC (CNS)Rudolf Arts PDC (CNS, CSCN)Serena Orr SPC, PDC (CACN)Seyed Mirsattari SPC (CSCN)Simon Walling SPC (CNSS)


CNSF Supporters

Actelion | SupporterActelion Pharmaceuticals Ltd is a biopharmaceutical company headquartered in Allschwil/Basel, Switzerland, focusing on the

discovery, development and commercialization of innovative treatments to serve high unmet medical needs. The CNSF values thesupport it has received from Actelion for 2013 which includes CNSF and Journal advertising.

Allergan | ExhibitorAllergan is a multi-specialty health care company established more than 60 years ago with a commitment to uncover the best of

science and develop and deliver innovative and meaningful treatments to help people reach their life’s potential. Today, we haveapproximately 10,000 highly dedicated and talented employees, global marketing and sales capabilities with a presence in more than100 countries, a rich and ever-evolving portfolio of pharmaceuticals, biologics, medical devices and over-the-counter consumerproducts, and state-of-the-art resources in R&D, manufacturing and safety surveillance that help millions of patients see more clearly,move more freely and express themselves more fully. Allergan is also the Medlearn Co-Founding Sponsor.

Athena Diagnostics | ExhibitorAthena Diagnostics is a leader in diagnostic testing for neurological diseases and offers innovative tests for Alzheimer’s disease,

muscular dystrophy, and other neuromuscular and developmental disorders. Athena, a division of Quest Diagnostics, is dedicated toproviding neurologists and other physicians and specialists with insights that can improve patient health. Athena provides the mostcomprehensive test menu and intellectual property portfolio for neurological, endocrine and renal conditions through more than 350diagnostic tests.

Bayer | ExhibitorAt Bayer, we put science to work in the areas of health, nutriction and high-tech materials. Across Canada and around the world,

we develop products that improve quailty of life for people, animals and communities. We are focused on achievement, supportentrepreneurship and share a common will to succeed. We value integrity, honesty, and openness, and we have respect for oneanother and the environment. We bring these values to life every day in the way we work.

Baylis | Exhibitor Baylis Medical Canada is a leading Canadian supplier and distributor with a long history of importing and distributing products into

the Canadian market. Baylis Medical distributes Kimberly-Clark's Pain Management system and Cyberonics Vagal Nerve StimulatorTherapy.

Canadian Stroke Network | ExhibitorThe Canadian Stroke Network’s mission is to reduce the impact of stroke on Canadians through collaborations that create valuable

new knowledge; to ensure the best knowledge is applied, and to build Canadian capacity in stroke. The Network is dedicated todecreasing the physical, social and economic consequences of stroke on the individual and on society. In pursuit of this goal, it aimsto: train researchers and practitioners, maximize health and economic benefits, build national consensus on stroke policy, createadded value through partnerships, and promote research excellence.

CareTrax Neuro | Exhibitor CareTrax Neuro Inc. is the Canadian office of Friendship Medical Electronics Ltd. Founded in 1992, Friendship specializes in the

design, development and manufacture of neurological devices used for EMG, EEG, ECG and IONM. The annual production exceeds20 million sets of 268 different models. Friendship holds a number of important patents that have filled gaps in the neurological deviceindustry.

Being equipped with advanced technologies and strong research and development capacity, Friendship is also able to providecustomized solutions to fit its clients' needs.

Carl Zeiss Canada | Exhibitor Carl Zeiss Canada strives to advance the status of medicine by driving the development of leading-edge technology and making

it available for routine applications. We are aware of the increasing cost pressure in health care and aspire to break new ground withour state-of-the-art innovations. Our extensive product portfolio allows simple, uninterrupted workflows which lead to more efficienttreatments.

Our neurosurgery portfolio includes a comprehensive line of surgical microscopes, visualization solutions and loupes thatuncompromisingly enhance visualization in the field of neurosurgery.


CNSF Supporters

Centogene | Supporter Centogene was founded in 2006 and has since been dedicated to the highest quality genetic and biochemical diagnostic testing

for the global medical community. We believe that the molecular understanding of rare disease allows for the coordination ofpersonalized and focused therapy and improved control of rare and congenital disease. As one of the world's leading companies inmolecular diagnostics, we also support clinicians with expert genetic counselling services. We deliver solutions for your rare diseasediagnostics on a laboratory scale. We believe that the best treatment to improve your patient's quality of life and disease state is earlydetection. Centogene also collaborates with both academic and industry partners on the development of new diagnostic techniques,biomarkers and orphan drugs.

The CNSF values the support it has received from Centogene for 2013 which includes the support of the Genetics of Neurologicand Neurodegenerative Syndromes Course. Centogene has had no imput into the course program content or speaker slection.

CIHI | Exhibitor We work with our stakeholders to create and maintain a broad range of health databases, measurements and standards. We also

help them better understand and use our evidence-based insight and analyses in their day-to-day decision-making. We developreports and analyses from our own data and other data sources. We do all of this in a way that ensures privacy and value for Canadiansand the Canadian health care system.

Codman Neuro DePuy Synthes | Bronze Sponsor Introducing Codman Neuro, part of the new DePuy Synthes companies. Inspired by listening carefully to what patients and

healthcare professionals have to say. United for greater ingenuity. Committed to superior quality. Driven to make a sizable impact onorthopaedic and neurological patient care. We are ready to advance patient care by delivering total solutions that go beyond theproducts themselves to help improve people’s lives. Codman Neuro develops and markets a wide range of diagnostic and therapeuticproducts for the treatment of central nervous system and vascular disorders, with a focus on neurovascular pathology, intractablepain management, pediatric & adult hydrocephalus and neuro critical care.

The CNSF values the support it has received from Codman Neuro for 2013, which includes: CNSF and Journal advertising, supportof Emergency Neurosurgery Resident Review course and Depuy Synthes for the Minimal Access Spine Surgery course and thelanyards. Neither Codman Neuro nor DePuy Synthes has had any input into the course’s program content or speaker selection.

Covidien | ExhibitorCovidien is a leading global healthcare products company that creates innovative medical solutions for better patient outcomes

and delivers value through clinical leadership and excellence. Covidien manufactures, distributes and services a diverse range ofindustry-leading product lines in three segments: Medical Devices, Pharmaceuticals and Medical Supplies.

Eisai | Exhibitor Eisai strives to find and develop new compounds that improve the lives of people in Canada in the areas of neurology and oncology.

Our neurology products include: Fycompa, for the adjunctive therapy in the management of partial-onset seizures in adult patientswith epilepsy who are not satisfactorily controlled with conventional therapy and Banzel, for the adjunctive treatment of seizuresassociated with Lennox Gastaut-Syndrome in children 4 years and older and adults. Our oncology products include Halaven, for thetreatment of patients with metastatic breast cancer who have previously received at least two chemotherapeutic regimens, Aloxi, forthe prevention of chemotherapy induced nausea and vomiting, and Gliadel Wafer, for the treatment of newly diagnosed glioma andrecurrent malignant glioblastoma.

electroCore Medical | Exhibitor Our gammaCore® non-invasive Vagus Nerve Stimulator is indicated for the acute and/or prophylactic treatment of Cluster

Headache and for the treatment of migraines in adults. gammaCore is intended for patient use PRN.electroCore® therapies are based on modulating how the brain responds to certain stimuli, processes pain, and controls the

autonomic nervous system. Changing how the brain directs itself and the body, in a non-invasive, convenient, and painless manneris based on a revolutionary use of specific, proprietary electrical signals.


CNSF Supporters

Ethicon | ExhibitorWith nearly 50 years of proven experience in hemostasis, ETHICONTM Biosurgery continues its dedication with cutting edge

technologies that are supported by clinical and economic evidence. With our Ethicon Biosurgery products, we offer the world’s mostcomprehensive portfolio of hemostasis solutions including proprietary oxidized regenerated cellulose hemostats (SURGICEL FAMILYincluding FIBRILLAR & SNOW), absorbable gelatin powder and sponges (SURGIFOAM), a flowable hemostatic matrix (SURGIFLO),synthetic sealant (OMNEX), and human fibrin sealant (EVICEL).

Fraser Health | Exhibitor Fraser Health, located in the Metro Vancouver and Fraser Valley region of British Columbia, has 20 culturally and geographically

diverse communities - from urban to rural. As the fastest growing region in the province, we provide health services to 1.6 millionpeople with 12 acute care hospitals, tertiary teaching hospitals, and services in public health, home health, mental health, andresidential care facilities. Our expansion means continued needs for Neurologists across the Lower Mainland and the Fraser Valley.We invite you to join us.

Galen Medical | ExhibitorGalen Medical is proud to be associated with the CNSF and participating at the 2013 meeting in Montreal. Established in 1986

and now a division of Keir Surgical Ltd., Galen Medical prides itself on working with neurosurgeons across Canada by providingsurgical technologies that are unique and innovative.

Products such as the Nico Myriad and the BrainPath are helping surgeons pratice minimally invasive neurosurgery with excellentpatient outcomes (click on the “news” icon for more information). The BoneScalpel from Misonix is another key product that allowsthe surgeon to perform the safest spine osteotomies while always sparing soft tissue.

GenedxBio unavailable

Genzyme | Bronze Sponsor In 1991, Genzyme introduced the first product ever approved to treat a lysosomal storage disorder, Ceredase® (alglucerase

injection). This first-generation enzyme replacement therapy product brought new hope to patients suffering from Type I Gaucherdisease. Since then, Genzyme has developed a second-generation Gaucher disease product, Cerezyme® (imiglucerase for injection),and introduced Fabrazyme® (agalsidase beta) for Fabry disease, Aldurazyme® (laronidase) for Mucopolysaccharidosis I (MPS I)and Myozyme® (alglucosidase alfa) for Pompe disease. As part of its commitment to new approaches to LSDs, Genzyme is developinga treatment for ASM-deficient Niemann Pick disease, a degenerative and fatal LSD. Acquired by Sanofi in 2011, Genzyme nowbenefits from the reach and resources of one of the world’s largest pharmaceutical companies, with a shared commitment to improvingthe lives of patients.

The CNSF values the support it has received from Genzyme which includes the support of the unaccredited Lunch ‘n Learn onTreatable Myopathies.

Grifols | Gold Sponsor Grifols is a global pharmaceutical company that develops and produces plasma-derived therapies and manufactures hospital

pharmacy products, intravenous solutions, diagnostic tools and medical devices. As the third largest global producer of plasmatherapies, Grifols has a presence in more than 90 countries and is the world leader in plasma collection, with 147 plasma donationcenters across the U.S.

The CNSF values the support it has received from Grifols for 2013, which includes: CNSF and Journal advertising, sponsorshipof the Course notes, CNSF advertising, the Neuromuscular SIG and Neuromuscular Course. Grifols has had no input into thesession(s) program content or speaker selection.

Health Match BC | Exhibitor Health Match BC is a free health professional recruitment service funded by the Government of British Columbia.


CNSF Supporters

Integra Canada ULC | ExhibitorWe are pleased to announce that as of April 1st 2013 we will be using our legal name of Integra Canada. Integra Lifesciences is

a leader in Neurosurgical Medical Devices. We are dedicated to limiting uncertainty for neurosurgeons so that they can concentrateon providing the best patient care. Integra’s broad portfolio of products include implants, devices, instruments and systems used inneurosurgery, neuromonitoring, neurotrauma, and related critical care. This year we are pleased to be featuring at our booth Integraproducts such as Mayfield, Duragen, CUSA, Licox, and Camino. Additionally, we will be featuring the innovative Visionsense 3DStereoscopic Camera System and our Mizuho line of instruments, aneurysm clips, and Sugita Headframes.

King Medical | ExhibitorKing Medical has been a Canadian distributor of needles and accessories since 1993. We maintain a large inventory allowing us to ship orders via UPS the same day. We carry products from Alpine Biomed, Ambu,

Chalgren, Dantec, Intronix, In Vivo Metric, Kendall, Mavidon, Natus, Nikomed, Parker Lab, Pharmaceutical Innovations, Technomed,3M, Vermed & Weaver …. and we have it in stock! We have the lowest prices in Canada on Ambu’s Single Patient Cup Electrodesand IOM Subdermal Needles.

Celebrating 20 years! “Free shipping to anywhere in Canada for orders over $750 (taxes not included)”.

Leica Microsystems | Exhibitor Leica Microsystems announces the NEW 2012 Leica OH Family of Neurosurgical microscopes. See and capture more detail than

ever before with brilliant 400 watt illumination and the new Leica HDC100 high definition surgical camera, a true reflection of Leicaphotographic excellence.

Maney Publishing | Exhibitor Maney Publishing's Health Sciences collection provides instant online access to over 25 international, peer-reviewed medical,

health science and health care journals in a wide range of fields, from hematology to neurology, and developmental disabilities tooccupational health. We also have a number of e-journal mini-bundles, consisting of three to four titles on Neurology & Neuroscience;Orthopedic Manual Physical Therapy; and Health & Social Care Management, at a simple 10% discount for institutions. ManeyPublishing is proud of these leading journals in the field of neurology: Journal of Spinal Cord Medicine, Neurological Research, andNutritional Neuroscience.

Medtronic | Silver SponsorGlobal leader in the industry, Medtronic is committed to advancing the treatment of spinal conditions. Our team has the most

comprehensive knowledge of modern fusion, dynamic stabilization, artificial disc replacement, biologics, balloon technologies andminimally invasive techniques to serve physicians who treat a broad variety of spinal disorders.

The CNSF values the support of Medtronic for 2013 which includes CNSF and Journal advertsing and support of the MinimallyInvasive Cranial Surgery and Canadian Neurosurgical Innovations and Discoveries Courses. Medtronic has had no input into theCourses’ program content or speaker selection.

Merck | Bronze SponsorToday's Merck is a global healthcare leader working to help the world be well. Through our prescription medicines, vaccines,

biologic therapies, and consumer care and animal health products, we work with customers and operate in more than 140 countriesto deliver innovative health solutions. We also demonstrate our commitment to increasing access to healthcare through far-reachingpolicies, programs and partnerships.

The CNSF values the support it has received from Merck for 2013, which includes: CNSF and Journal advertising, the sponsorshipof the Delegate Bag and the Fairmont Hotel Keycards.

Natus | ExhibitorNatus is the leading provider of healthcare products used for screening, detection, treatment, monitoring and tracking of common

medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, and balance and mobilitydisorders. Product offerings include computerized neurodiagnostic systems for audiology, neurology, polysomnography and softwaresystems for managing and tracking disorders and diseases for public health laboratories. Neonatology product offerings includehearing screening systems, phototherapy devices for jaundice management, incubators and infant warmers for thermoregulation andhead-cooling products for newborn brain injury treatment.


CNSF Supporters

NeuroSource Medical | ExhibitorNeuroSource Medical Inc. is a Canadian-owned neurodiagnostic distribution company founded by a professional staff with a

combined 70 years of clinical electrophysiological experience and a clear understanding of every product they sell. The company’sMedical Advisory Board, with MD and PhD representation from across Canada, affords its customers an expert opinion on all theirproducts from leaders in their respective fields. The combination of this clinical and technical knowledge and NeuroSource Medical’srelationships with the leading manufacturers ensures their customer’s complete satisfaction and provides them a level of service andexperience previously not available here in Canada.

NHCC | Exhibitor Neurological Health Charities Canada (NHCC) is a collective of organizations that represent people with chronic, often progressive,

neurological and/or neuromuscular diseases, disorders, conditions and injuries (brain conditions) in Canada. The NHCC’s role is toprovide leadership, evaluating and advancing new opportunities for collaboration specific to advocacy, education and research projects,related to brain health.

Nihon Kohden | ExhibitorNihon Kohden’s long legacy in EEG diagnostics and monitoring continues with the EEG-1200 that combines EEG, Long Term

Epilepsy Monitoring (LTM), cEEG ICU Monitoring (QP-160A) and Sleep Testing for the most flexible and comprehensive recordingsystem delivering the highest quality patient care as efficiently as possible.

Novartis| ExhibitorNovartis Pharmaceuticals Canada Inc., a leader in the healthcare field, is committed to the discovery, development and marketing

of innovative products to improve the well-being of all Canadians. In 2012, the company invested close to $100 million in researchand development in Canada. Novartis Pharmaceuticals Canada Inc. employs more than 600 people in Canada.

Parkinson Society Canada | SupporterParkinson Society Canada is the national voice of the more than 100,000 Canadians living with Parkinson’s, a neurodegenerative

disease. From diagnosis to discovery, Parkinson Society Canada is there at every point along the Parkinson’s journey, providingeducation, advocacy and support services to individuals and health care professionals since 1965. Funding innovative research helpsexpand knowledge on prevention, diagnosis and treatment of Parkinson’s and will ultimately lead to a cure.

The CNSF values the support of the Parkinson’s Society of Canada which includes: CNSF advertising and support of theunaccredited Lunch ‘n Learn on the Canadian Guidelines on Parkinsons’s Disease.

Pfizer | SupporterFounded in 1849, Pfizer is the world's largest research-based biopharmaceutical company, constantly looking at new approaches

to better health. We discover and develop innovative medicines to treat and help prevent disease for both people and animals. Throughconsistent, high-quality manufacturing and distribution operations, our medicines reach patients in 180 nations. We also partner withhealthcare providers, governments and local communities around the world to expand access to our medicines and to provide betterquality healthcare and health system support. At Pfizer, our colleagues work every day to help people lead longer, healthier lives andto reduce the human and economic burden of disease worldwide.

The CNSF values the support it has received from Pfizer for 2013.

Roxon Medi-Tech Ltd. | Exhibitor Founded in 1975, Roxon Medit-tech Ltd. is a 100% Canadian owned corporation dedicated to supplying the quality specialized

equipment to medical facilities across Canada. Our focus is in Cardiac, Respiratory and Neurology equipment.

Scotiabank | Silver Sponsor Scotiabank is a proud Canadian financial institution, providing customers with full-service banking, including tailored financing

options, wealth management, and investment planning. Our dedicated advisors offer the Scotia Professional® Plan, a customizedfinancial package designed to allow you to focus on patient care while building a successful practice. Members of the CanadianNeurological Sciences Federation qualify for preferred rates and discounts. To learn more, contact your advisor at your local branch.

The CNSF values the support it has received from Scotiabank for 2013, including CNSF and Journal advertising, the ScotiaProfessional Plan for Members and the unaccredited Lunch n’ Learn entitled A Practical Financial Roadmap for Neurological andNeurosurgical Residents.


CNSF Supporters

Stryker | Exhibitor Stryker is one of the world’s leading medical technology companies and is dedicated to helping healthcare professionals perform

their jobs more efficiently while enhancing patient care. Stryker is a leader in creating surgical instruments that make surgery moreefficient, reduce trauma and improve techniques. Through close collaboration with leading surgeons worldwide, StrykerCraniomaxillofacial has gained a well-earned reputation as a market leader for its innovative developments in Craniomaxillofacialand Neurosurgery. In order to maintain this spirit of innovation and leadership, we continuously focus our research and developmentof biomaterials, fixation systems and radio frequency.

Teva Canada Innovation | Silver SponsorTeva Canada Innovation is the Canadian innovative division of Teva Pharmaceutical Industries Limited. We have become the

undisputed leader in the treatment of relapsing-remitting multiple sclerosis in the country, and we also launched two (2) other productsfor the treatment of neurological diseases, namely Parkinson’s disease and migraine. In our pursuit to improve the health of Canadians,we intend to continue to put the patient at the heart of everything we do, and to work hand in hand with them, their families and theirphysicians. Our mission is to innovate, assist, reassure … one patient at a time!

The CNSF values the support it has received from Teva Canada Innovation for 2013, which includes: CNSF and Journal Advertising,support of the MS Course and as the Medlearn Co-Founding Sponsor. Teva has had no input into the course’s program content orspeaker selection.

Tourisme Montreal | Supporter Tourisme Montréal is a private, non-profit organization, founded in 1919 and incorporated in 1924. Its mission is to assume

leadership of the collective effort to promote and position Montréal as a premier destination for business and leisure travel as well asto create business opportunities for its members and partners. Tourisme Montréal organizes many activities, in Canada and aroundthe world, with a particular focus on attracting meetings and conventions to the city. The organization also provides event plannersand specialized foreign press with unsurpassed logistical support, and is the driving force behind many tools and initiatives designedto promote Montréal as a leisure destination. Above all, Tourisme Montréal is committed to ensuring that all visitors to our city receivea warm welcome from all industry stakeholders.

Tourisme Quebec | Bronze SponsorQuébec is truly a unique land in North America. Unique for its geography, its history and its culture, which together have forged its

bold and exuberant identity. Simply put, Québec is warmth, absolute authenticity and intensity, all within easy reach! To help you planyour Québec vacation, we've put together a wealth of useful information on everything there is to see and do, as well as on thepractical aspects of your stay. User-friendly search tools will assist you in your quest for information. Come experience everythingQuébec has to offer!

UCB Canada Inc. | Platinum SponsorAt UCB Canada Inc. we aspire to be the Patient-Centric global biopharmaceutical leader transforming the lives of people with

severe diseases.The CNSF values the support it has received from UCB for 2013, which includes: CNSF and Journal advertising, sponsorship of

the Epilepsy Co-Developed Industry Symposium and the Epilepsy Video Review SIG. UCB has had no input into either sessions’program content or speaker selection.

Zimmer | Exhibitor Founded in 1927 and headquartered in Warsaw, Indiana, Zimmer designs, develops, manufactures and markets orthopaedic

reconstructive, spinal and trauma devices, dental implants, and related surgical products. Zimmer has operations in more than 25countries around the world and sells products in more than 100 countries. Zimmer’s 2011 sales were approximately $4.5 billion. TheCompany is supported by the efforts of more than 8,000 employees worldwide.


Canadian Association of Neuroscience Nurses

The Quebec Chapter of the Canadian Association of Neuroscience Nurses (CANN) is proud to be hostingthe 2013 CANN Annual General Meeting and Scientific Sessions. The conference is being held at theFairmont Queen Elizabeth Hotel, ideally situated above the VIA Rail station and two blocks from the hub ofMontreal shopping on Ste. Catherine Street.

We are very pleased to present an excellent scientific program highlighting the latest developments in aspectsof neurology and neurosurgery, as well as networking opportunities for neuroscience nurses and ourcolleagues. Please join us for our Welcome Reception taking place on Tuesday June 11th @1800 at theMontreal Neurological Hospital and Institute.

During our 3 day conference we will hear from neuroscientists and nurseresearchers in plenary sessions, and have the opportunity to learn hands-on skills at workshops led by advanced practice neuroscience nurses. Aswell, participants can select from among 22 additional concurrent scientificsessions covering a range of neuroscience nursing issues includingpediatrics, ethics, stroke, multiple sclerosis, neuro-critical care and neuro-modulation.

This June, we will be showcasing the first Canadian Neuroscience Nursingtextbook, “Navigating Neuroscience Nursing: A Canadian perspective”. Thisimpressive text has contributions from highly skilled Canadian neurosciencenurses and is a very welcome addition to our libraries.

We hope you can join us for our annual ‘Run/Walk for Research’ to supportnursing research awards. This 5 km “fun run” or 3-5 km “fun walk” is onThursday June 13th @0630. Meet in the lobby of the Fairmont QueenElizabeth for a bright and early start to your day.

In addition to our annual pub crawl, we are co-hosting a more stylish dining event for CNSF and CANN.Please join us for the CANN /CNSF Dinner at the historic McGill Faculty Club on Thursday June 13th.

And finally, we would like to wish our colleagues at the Canadian Neurological Science Federation’s 48thAnnual Congress all the best for a very successful conference.

Erik De Agostinis & Martha A. Stewart Rosa Sourial & Toni VitaleCANN Program Co Chairs, 2013 CANN Scientific Co-Chairs, 2013

The Canadian Association of Neuroscience Nurses44th Annual Meeting and Scientific Sessions, June 11-14, 2013, Montreal QuebecGenerating the flow of knowledge


Associates and Affiliates

The Canadian Neurological Sciences Federation and the Affiliate Societies

The CNSF and its Affiliate Societies work collaboratively whenever and wherever possible throughout the year. The CNSF valuesand appreciates this partnership.

One of the most important tasks the Affiliates undertake is to assist the CNSF, when requested, in providing leadership and planningfor Congress sessions which fall within their area of expertise. Thank you.

The Canadian Neurological Sciences Federation and the Associate Societies

Associate Societies of the CNSF are professional societies that have similar goals to the CNSF.

Canadian Association of Neuroscience Nurses (CANN)

Canadian Association of Electroneurophysiology Technologists Inc. (CAET)

The Association of Electromyography Technologists of Canada (AETC)

Canadian Association for Neuroscience (CAN)

Canadian Association of Physical Medicine & Rehabilitation (CAPM&R)

Canadian ALS Research Network (CALS)

The Canadian Brain Tumour Consortium

The Canadian Headache Society

The Canadian League Against Epilepsy

The Canadian Movement Disorders Group

The Canadian Network of MS Clinics

The Canadian Neurocritical Care Society

The Canadian Neuromuscular Group

The Canadian Stroke Consortium

The Consortium of Canadian Centres for ClinicalCognitive Research (C5R)


Canada Helps

CSCN National Fellowship

DONATE to the NSFC and enhance our support of neurological initiatives and activities

The Canadian Society of Clinical Neurophysiologists (CSCN) wishes to announce that Dr. Colin Josephson has beenawarded the Canadian National Clinical Fellowship in Epilepsy & Electroencephalography.

This fellowship was made possible by an unrestricted educational grant from UCB Canada, Inc. Thank you UCB!

Congratulations Dr. Josephson.


2014 CNSF Congress in Beautiful Banff AlbertaOnce again we have secured an outstanding hotelproperty as our Congress venue and host hotel. Wewill be at the Fairmont Banff Springs Hotel – June3 to June 6, 2014!Few hotels in the world rival the majesty, hospitalityand grandeur of The Fairmont Banff Springs resort,located in the heart of Banff National Park, a UNESCOWorld Heritage Site. This hotel was styled after aScottish Baronial Castle and when it opened in 1888,it marked the birthplace of tourism in the CanadianRockies.The Fairmont Banff Springs hotel, a National HistoricalSite of Canada, provides unparalleled options andunique experiences to guests, from inclusive onsitegetaways to days of adventure exploring the Rockies. For the convenience of our Congress delegates, the CNSF has reservedtransportation from the Calgary International Airport directly to Banff, through Brewster Corporate Event and Management. Thefee is $40.50 per person, about the same as a taxi fare from the airport to a downtown Calgary Hotel. Enjoy the ride and enjoy

the scenery.During your stay in our Rocky Mountains, we invite you to join yourcolleagues for a truly Western barbeque experience amid the majesticmountain peaks.

Just minutes from Banff at Brewster’s Mountainview location we willgather ’round the indoor central bonfire for an evening of entertainmentand feasting. Transportation to and from the venue is provided.

Then, looking forward to 2015! The CNSF 50th AnnualCongress! Hope to see you all at the Fairmont Royal York Hotel inToronto, June 9 to June 12, 2015.

The CNSF is committed to providing its Members with access to e-CPD opportunities. Medlearn is now the e-cpdrepository providing CNSF Members with links to other organizations, resources and reports in the attainment of Section1, 2, and 3 MOC credits. We are working collaboratively with Canadian Universities and Organizations and Internationalorganizations offering online CPD by posting descriptions and direct links to organizations and resources. Caregiverand Patient Resources will remain open access, with access to CPD resources being password protected. CNSFMembers (Member ID and Password required)please visit: http://www.cnsfederation.org/cnsf/medlearn/. Please sendyour suggestions regarding e-CPD Organizations and Resources to [email protected].

The Medlearn Committee consists of Mandar Jog, Chair and members Jeanne Teitelbaum, Ron Pokrupa andRobert Hammond. The CNSF also wishes to thank Medlearn’s co-founding sponsors Teva Canada Innovationand Allergan

Photo Credit: Banff Lake Louise Tourism

Medlearn


Actelion - CNSF and Journal advertising.

Centogene - support of the Genetics of Neurologic and Neurodegenerative Syndromes Course. Centogene has had noinput into the course’s program, content or speaker selection.

Codman Neuro/Depuy Synthes - CNSF and Journal advertising, support of Emergency Neurosurgery Resident Reviewcourse and Depuy Synthes for the Minimal Access Spine Surgery course and the lanyards. Neither Codman Neuronor Depuy Synthes has had any input into the courses’ program, content or speaker selection.

Genzyme - support of the unaccredited Lunch n Learn on Treatable Myopathies.

Grifols - sponsorship of the Course notes, CNSF and Journal advertising, the Neuromuscular SIG and NeuromuscularCourse. Grifols has had no input into the session(s) program content or speaker selection.

Medtronic - CNSF and Journal advertising, support of the Minimally Invasive Cranial Surgery and CanadianNeurosurgical Innovations and Discoveries Courses. Medtronic has had no input into the Courses program contentor speaker selection.

Merck - CNSF and Journal advertising, the sponsorship of the Delegate Bag and the Fairmont Hotel Keycards.

Parkinson Society Canada - CNSF advertising and support of the unaccredited Lunch n Learn on the CanadianGuidelines on Parkinson’s Disease.

Scotiabank - CNSF and Journal advertising, the Scotia Professional Plan for Members and the unaccredited Lunch nLearn entitled A Practical Financial Roadmap for Neurological and Neurosurgical Residents.

Teva Canada Innovation - CNSF and Journal advertising, support of the MS Course and as the Medlearn Co-FoundingSponsor. Teva has had no input into the course’s program content or speaker selection.

UCB Canada Inc. - CNSF and Journal advertising, sponsorship of the Epilepsy Co-Developed Industry Symposiumand the Epilepsy Video Review SIG. UCB has had no input into either sessions’ program content or speakerselection.

Major Supporters

The support the CNSF receives from all business sectors is vital to our survival. Without this support the CNSF, its Journal and Congress could not likely survive. Our major supporters are listed below.

Thank you all

Richness is:Richness is:

® Registered trademarks of The Bank of Nova Scotia.

Richness is:

You define richness. With the Scotia Professional® Plan, we can help with the money part. You’ve worked long and hard to build your career. It only makes sense to do everything you can to ensure your continued success, both professionally and personally. The Professional Plan is a fully customized banking package designed to help you build a strong, profitable business while ensuring your personal finances receive the attention they deserve. Which gives you more time to explore the universe within.

To learn more about Scotia Professional Plan, visit your nearest Scotiabank branch or visit scotiabank.com/professional today.

Scotia Professional Plan

North America / Canada / Québec QuebecOriginal.com1 877 BONJOUR

château

tripant

joie de vivre

Documents

CNSF Supporters - Canadian Neurological Sciences Federation